273 related articles for article (PubMed ID: 27701081)
1. Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors.
Hall JJ; Bolina M; Chatterley T; Jamali F
Ann Pharmacother; 2017 Feb; 51(2):163-178. PubMed ID: 27701081
[TBL] [Abstract][Full Text] [Related]
2. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K
Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980
[TBL] [Abstract][Full Text] [Related]
3. Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.
Wang X; Song Y; Wang J; He J; Liu R; Li X; Huang H; Zhang J
Int J Clin Pharm; 2020 Feb; 42(1):23-30. PubMed ID: 31916121
[TBL] [Abstract][Full Text] [Related]
4. Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review.
Colebatch AN; Marks JL; van der Heijde DM; Edwards CJ
J Rheumatol Suppl; 2012 Sep; 90():62-73. PubMed ID: 22942332
[TBL] [Abstract][Full Text] [Related]
5. [A Survey of the Adverse Effects and Influence of Concomitant Drugs for Methotrexate Intrathecal Administration].
Uchiyama M; Ueno M; Takamatsu Y; Matsuo K; Imakyure O; Kamimura H
Yakugaku Zasshi; 2018; 138(1):111-115. PubMed ID: 29311456
[TBL] [Abstract][Full Text] [Related]
6. [Proton Pump Inhibitor and High-dose Methotrexate: Two Cases Reports].
Evrard J; Farnier E; Carcel C; Lachenal F; Vial T; Pont E
Therapie; 2015; 70(6):527-35. PubMed ID: 26242498
[TBL] [Abstract][Full Text] [Related]
7. A non-interventional retrospective cohort study of the interaction between methotrexate and proton pump inhibitors or aspirin.
Boerrigter E; Crul M
Ann Pharm Fr; 2017 Sep; 75(5):344-348. PubMed ID: 28705331
[TBL] [Abstract][Full Text] [Related]
8. Interaction between nonsteroidal anti-inflammatory drugs and high-dose methotrexate: a literature review.
Fischetti LF
J Pediatr Oncol Nurs; 1990 Jan; 7(1):14-6. PubMed ID: 2194502
[TBL] [Abstract][Full Text] [Related]
9. Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
Wang SF; Huang KW; Chou YC; Lee HC; Wu PK; Chen WM; Hung GY; Chang YL
Cancer Med; 2023 Jun; 12(11):12354-12364. PubMed ID: 37062070
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
11. [Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].
Bertin P; Carpentier N; Vergne P; Bonnet C; Bannwarth B; Dehais J; Treves R
Therapie; 1997; 52(2):133-7. PubMed ID: 9231508
[TBL] [Abstract][Full Text] [Related]
12. A critical review of methotrexate clinical interactions: role of transporters.
Jafari F; Arasteh O; Hosseinjani H; Allahyari A; Ataei Azimi S; Askari VR
Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):91-107. PubMed ID: 36946211
[TBL] [Abstract][Full Text] [Related]
13. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
Svanström H; Lund M; Melbye M; Pasternak B
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.
Franck H; Rau R; Herborn G
Clin Rheumatol; 1996 May; 15(3):266-70. PubMed ID: 8793258
[TBL] [Abstract][Full Text] [Related]
15. Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.
Montagnani S; Tuccori M; Testi A; Cristofano M; Corona T; Salvadori S; Scarpignato C; Blandizzi C
Int J Clin Pharm; 2016 Aug; 38(4):829-37. PubMed ID: 27003828
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
Wang X; Tian HJ; Yang HK; Wanyan P; Peng YJ
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):876-80. PubMed ID: 21900785
[TBL] [Abstract][Full Text] [Related]
17. Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.
Reeves DJ; Moore ES; Bascom D; Rensing B
Br J Clin Pharmacol; 2014 Sep; 78(3):565-71. PubMed ID: 24646036
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine.
Marlicz W; Loniewski I; Grimes DS; Quigley EM
Mayo Clin Proc; 2014 Dec; 89(12):1699-709. PubMed ID: 25440891
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.
Franck H; Rau R; Herborn G
Clin Rheumatol; 1996 Mar; 15(2):163-7. PubMed ID: 8777850
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate and nonsteroidal antiinflammatory drug interactions.
Frenia ML; Long KS
Ann Pharmacother; 1992 Feb; 26(2):234-7. PubMed ID: 1554938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
